Search Videos and More
News
Like Mother, Like Son
A mother and son’s talents and a duo of DAISY awards.
Course
23rd Annual Highlights of the 2024 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this education program is designed to help medical, radiation, and surgical oncologists, gynecologists, and radiologists translate the data from key presentations of the 2024 San Antonio Breast Cancer Symposium into practice. New options for the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease will be discussed. In addition, we will address new strategies for optimizing existing treatments.
Course
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
The Fox Chase genitourinary oncology team cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.
News
Fox Chase Cancer Center and Lewis Katz School of Medicine Researchers Identify Where to Target Interventions to Reduce Disparities in Aggressive Prostate Cancer
Researchers at Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University have identified factors that, if addressed, could decrease incidence of aggressive prostate cancer in areas where rates are highest — often Black communities with high rates of poverty.
News
Tackling Anything Patients Need Before, During, and After Urologic Surgery
Growing up, Mary Ellen Day was athletic and focused—dreaming that one day, she would become a ‘real’ cheerleader.
News
Fox Chase Cancer Center Welcomes Dr. J. Ryan Mark
Fox Chase Cancer Center is pleased to announce the hiring of J. Ryan Mark, MD, FACS, as an Associate Professor in the Department of Urology at Fox Chase Cancer Center and a Fox Chase – Temple Urologic Institute provider.
News
ENDING THE RELIANCE ON BCG
A Phase III clinical trial for bladder cancer
Document
DEPARTMENT OF HEMATOLOGY/ONCOLOGY THORACIC CANCERS CLINICAL TRIALS
For general questions about clinical trials, call 215-214-1515 or visit FoxChase.org/ClinicalTrials.
News
Venturing into New Treatment Territories for Myelofibrosis with a Fox Chase Investigator-Initiated Study
The study is a phase one, single-site, dose-escalation study for patients with myeloproliferative neoplasms unresponsive to any JAK2 inhibitor. It combines two oral medications, Pacritinib and Talazoparib, and is for transplant-ineligible patients.
Symposium
Thoracic Malignancies: A Review of the Latest Evidence
Great therapeutic strides have been made for non-small cell lung cancer (NSCLC). In this CME, renowned specialists from Fox Chase Cancer Center, Temple Lung Center, Johns Hopkins Medicine, Yale Medicine, MedStar Georgetown University Hospital, Jefferson Health, and Penn Medicine will present innovative treatment modalities that include medical, surgical and radiation oncology, pulmonology, and radiologic options.
News
LUNG CANCER PROGRAM
Comprehensive Care That Empowers Patients Through Risk Assessment, Prevention, Detection, Treatment, and Survivorship
News
Fox Chase Cancer Center’s Dr. Thomas J. Galloway Named a Fellow of the American Society for Radiation Oncology
Thomas J. Galloway, MD, Chief of the Division of Head and Neck Radiation Oncology at Fox Chase Cancer Center, was today named a Fellow of the American Society for Radiation Oncology (ASTRO) at its 66th Annual Meeting in Washington, D.C.